Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2025-12-26 @ 9:42 PM
Study NCT ID:
NCT01710995
Status:
COMPLETED
Last Update Posted:
2012-10-19
First Post:
2012-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
Sponsor:
Norgine
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZEG-02/2010 (BE)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None